271 related articles for article (PubMed ID: 1573283)
1. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
[TBL] [Abstract][Full Text] [Related]
2. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
Reiter Z; Tomson S; Ozes ON; Taylor MW
Blood; 1993 Apr; 81(7):1699-708. PubMed ID: 8096405
[TBL] [Abstract][Full Text] [Related]
3. Consensus interferon induces peak mRNA accumulation at lower concentrations than interferon-alpha 2a.
Klein SB; Blatt LM; Taylor MW
J Interferon Res; 1993 Oct; 13(5):341-7. PubMed ID: 8301154
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the in vitro host range of recombinant met-interferon-con1, interferon-alpha 2b, and interferon-beta [corrected].
Hu CJ; Ozes ON; Klein SB; Blatt LM; Taylor MW
J Interferon Cytokine Res; 1995 Mar; 15(3):231-4. PubMed ID: 7584668
[TBL] [Abstract][Full Text] [Related]
5. Cytokine and natural killing regulation of growth of a hairy cell leukemia-like cell line: the role of interferon-alpha and interleukin-2.
Reiter Z; Ozes ON; Blatt LM; Taylor MW
J Immunother (1991); 1992 Jan; 11(1):40-9. PubMed ID: 1734947
[TBL] [Abstract][Full Text] [Related]
6. Biologic activities of natural and synthetic type I interferons.
Pfeffer LM
Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-63-S9-69. PubMed ID: 9208874
[TBL] [Abstract][Full Text] [Related]
7. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
[TBL] [Abstract][Full Text] [Related]
8. The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon.
Blatt LM; Davis JM; Klein SB; Taylor MW
J Interferon Cytokine Res; 1996 Jul; 16(7):489-99. PubMed ID: 8836913
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
Losinno C; Wines BD; Johns TG; Mackay IR
Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
[TBL] [Abstract][Full Text] [Related]
10. Comparative antiproliferative and receptor binding activities of interferons alpha and beta on lymphoblastoid and melanoma cells.
Hertzog PJ; Johns TG; Callister KA; Dinatale A; Linnane AW
Biochem Int; 1990 Dec; 22(6):1095-102. PubMed ID: 2151021
[TBL] [Abstract][Full Text] [Related]
11. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
Platsoucas CD
Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722
[TBL] [Abstract][Full Text] [Related]
12. Comparison of an antiviral activity of recombinant consensus interferon with recombinant interferon-alpha-2b.
Koyama AH; Arakawa T; Adachi A
Microbes Infect; 1999 Nov; 1(13):1073-7. PubMed ID: 10572309
[TBL] [Abstract][Full Text] [Related]
13. Effect of indomethacin, aspirin, and acetaminophen on in vitro antiviral and antiproliferative activities of recombinant human interferon-alpha 2a.
Takaoki M; Yamashita Y; Koike K; Matsuda S
J Interferon Res; 1988 Dec; 8(6):727-33. PubMed ID: 3230331
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of interferon-consensus 1, interferon-alpha 2a, and interferon-beta 1b on HLA expression and lymphoproliferation: a preclinical model for treatment of multiple sclerosis.
Dhib-Jalbut S; Jiang H; Xia Q; Blatt L; Johnson KP; Hilt D
J Interferon Cytokine Res; 1996 Mar; 16(3):195-200. PubMed ID: 8697141
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the antiviral activities of natural IFN-alpha preparations and their subtype compositions.
Yanai Y; Sanou O; Kayano T; Ariyasu H; Yamamoto K; Yamauchi H; Ikegami H; Kurimoto M
J Interferon Cytokine Res; 2001 Oct; 21(10):835-41. PubMed ID: 11710996
[TBL] [Abstract][Full Text] [Related]
16. Differential neutralizing activity of human antibodies in interferon antiviral and natural killer cell bioassays.
Thurmond LM; Reese MJ
J Interferon Cytokine Res; 1997 Oct; 17(10):619-23. PubMed ID: 9355963
[TBL] [Abstract][Full Text] [Related]
17. Biological characterization of three novel variants of IFN-alpha 13 produced by human placental trophoblast.
Fink T; Zachar V; Ebbesen P
Placenta; 2001; 22(8-9):673-80. PubMed ID: 11597187
[TBL] [Abstract][Full Text] [Related]
18. Different interactions of interferon-alpha subtypes at the surface of epithelial and lymphoid cells.
Overall ML; Chambers P; Hertzog PJ
J Interferon Res; 1992 Aug; 12(4):281-8. PubMed ID: 1431308
[TBL] [Abstract][Full Text] [Related]
19. Temperature influences on different human alpha interferon activities.
Hirai N; Hill NO; Osther K
J Interferon Res; 1984; 4(4):507-16. PubMed ID: 6094682
[TBL] [Abstract][Full Text] [Related]
20. [Growth inhibition of melanoma cells by interferons in vitro. Similar antiproliferative effects of 100-1000 times lower concentrations of nIFN-beta in comparison with rIFN-alpha-2a].
Zouboulis C; Garbe C; Orfanos CE
Hautarzt; 1989 Feb; 40(2):65-9. PubMed ID: 2714987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
